Lexaria Bioscience Corp. (LEXX)
3.08
+0.09
(+3.01%)
USD |
NASDAQ |
Oct 23, 16:00
3.00
-0.08
(-2.60%)
After-Hours: 20:00
Lexaria Bioscience Price : 3.08 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.98 | 3.199 | 2.84 | 3.08 | 23234.00 |
| Oct 22, 2026 | 2.74 | 3.00 | 2.510 | 2.99 | 16561.00 |
| Oct 21, 2026 | 2.68 | 2.89 | 2.516 | 2.82 | 28671.00 |
| Oct 20, 2026 | 2.60 | 2.68 | 2.46 | 2.65 | 42015.00 |
| Oct 19, 2026 | 2.79 | 2.85 | 2.430 | 2.60 | 45348.00 |
| Oct 16, 2026 | 3.19 | 3.24 | 2.81 | 2.86 | 128062.0 |
| Oct 15, 2026 | 2.74 | 3.110 | 2.74 | 2.99 | 38661.00 |
| Oct 14, 2026 | 2.81 | 2.920 | 2.43 | 2.82 | 103878.0 |
| Oct 13, 2026 | 3.29 | 3.29 | 2.69 | 2.80 | 118025.0 |
| Oct 12, 2026 | 3.18 | 3.624 | 3.18 | 3.27 | 66135.00 |
| Oct 09, 2026 | 3.31 | 3.90 | 3.12 | 3.32 | 200675.0 |
| Oct 08, 2026 | 3.50 | 3.669 | 3.19 | 3.20 | 26502.00 |
| Oct 07, 2026 | 3.14 | 3.59 | 3.10 | 3.46 | 76927.00 |
| Oct 06, 2026 | 2.925 | 3.24 | 2.86 | 3.24 | 66068.00 |
| Oct 05, 2026 | 2.90 | 3.125 | 2.77 | 2.77 | 40222.00 |
| Oct 02, 2026 | 3.18 | 3.24 | 2.80 | 2.88 | 81261.00 |
| Oct 01, 2026 | 3.20 | 3.25 | 2.95 | 3.09 | 48659.00 |
| Sep 30, 2026 | 3.21 | 3.29 | 3.06 | 3.15 | 23129.00 |
| Sep 29, 2026 | 3.28 | 3.340 | 2.98 | 3.13 | 77524.00 |
| Sep 28, 2026 | 3.25 | 3.460 | 3.15 | 3.225 | 41924.00 |
| Sep 25, 2026 | 3.455 | 3.455 | 3.15 | 3.28 | 34210.00 |
| Sep 24, 2026 | 3.29 | 3.595 | 3.142 | 3.37 | 52964.00 |
| Sep 23, 2026 | 3.31 | 3.34 | 3.10 | 3.235 | 14382.00 |
| Sep 22, 2026 | 3.54 | 3.84 | 3.08 | 3.22 | 107262.0 |
| Sep 21, 2026 | 3.29 | 3.48 | 3.15 | 3.425 | 25962.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Target Group, Inc. (Canada) | 0.001 |
| InMed Pharmaceuticals, Inc. | 1.44 |
| XORTX Therapeutics, Inc. | 0.9201 |
| NervGen Pharma Corp. | 1.43 |
| Milestone Pharmaceuticals, Inc. | 0.6482 |
Price Related Metrics
| PS Ratio | 23.86 |
| Price to Book Value | 1.074 |
| Earnings Yield | -171.4% |
| Market Cap | 5.090M |